Skip to main content
. 2020 Apr 23;8(1):e001061. doi: 10.1136/bmjdrc-2019-001061

Figure 1.

Figure 1

Prevalence of microvascular (retinopathy and nephropathy) and macrovascular (acute coronary syndrome, cerebrovascular, and peripheral arterial disease) diseases present at time of the diagnosis of type 2 diabetes according to glycemic status in the 3 years before the diagnosis of type 2 diabetes. A microvascular disease was considered being present at time of type 2 diabetes diagnosis if the condition was diagnosed between 5 years before and 15 months after the diagnosis of type 2 diabetes. A macrovascular disease was considered being present at time of type 2 diabetes diagnosis if the condition was diagnosed any time before the diagnosis and during the year following the diagnosis of type 2 diabetes. For the detection of pre-diabetes, the WHO/International Expert Committee diagnostic criteria were adopted (FPG: 6.1–6.9 mmol/L, OGTT 7.8–11.1 mmol/L, HbA1c 42 to 47 mmol/mol or 6.0%–6.4%). FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; T2D, type 2 diabetes.